Avadel Legacy Pharmaceuticals, LLC
Records under this name other than the patents Avadel Legacy Pharmaceuticals, LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 4 patents it holds.
Showing 1 to 9 of 9 · Back to Avadel Legacy Pharmaceuticals, LLC
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,493,051 | Cysteine Composition and Injection Formerly held In force · High confidence | In force | High confidence | |
| US 10,543,186 | Cysteine Composition and Injection Formerly held In force · High confidence | In force | High confidence | |
| US 10,702,490 | Cysteine Composition and Injection Formerly held In force · High confidence | In force | High confidence | |
| US 11,045,438 | Cysteine Composition and Injection Formerly held In force · High confidence | In force | High confidence | |
| US 7,906,145 | Oral Pharmaceutical Formulation in the Form of Aqueous Suspension for Modified Release of Active Principle(S) Term ended Term ended Sep 26, 2025 · High confidence | Term ended | Term ended Sep 26, 2025 | High confidence |
| US 7,683,024 | Polyaminoacids Functionalized by Alpha Tocopherol and Uses Thereof, Particular for Therapeutic Applications Term ended Term ended Jul 19, 2023 · High confidence | Term ended | Term ended Jul 19, 2023 | High confidence |
| US 9,814,684 | Oral Pharmaceutical Formulation in the Form of Aqueous Suspension for Modified Release of Active Principle(S) Term ended Term ended Apr 7, 2023 · Medium confidence | Term ended | Term ended Apr 7, 2023 | Medium confidence |
| US 10,004,693 | Oral Pharmaceutical Formulation in the Form of Aqueous Suspension for Modified Release of Active Principle(S) Term ended Ended no later than Apr 7, 2023 · Medium confidence | Term ended | Ended no later than Apr 7, 2023 | Medium confidence |
| US 8,679,540 | Pharmaceutical formulations for the prolonged release of active principle(s), and their applications, especially therapeutic applications Surrendered on reissue Surrendered on reissue Jan 30, 2018 · Low confidence | Surrendered on reissue | Surrendered on reissue Jan 30, 2018 | Low confidence |